Stonepine Capital Management »

Alimera Sciences Inc Cvr shares owned by Stonepine Capital Management

Quarter-by-quarter ownership of Alimera Sciences Inc Cvr shares owned by Stonepine Capital Management from 13F filings

Historical chart of Stonepine Capital Management investment in Alimera Sciences Inc Cvr

Tip: Access up to 7 years of quarterly data

All positions including Alimera Sciences Inc Cvr held by Stonepine Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alimera Sciences Inc Cvr by Stonepine Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $107k 2.4M 0.04
2024-09-30 $96k 2.4M 0.04

More positions owned by Stonepine Capital Management

Adma Biologics (ADMA)
Evolus (EOLS)
Tela Bio (TELA)
Galapagos Nv- Spon Adr (GLPG)
Zevra Therapeutics Com New (ZVRA)
Verastem Com New (VSTM)
ACADIA Pharmaceuticals (ACAD)
Optinose Com New
Anika Therapeutics (ANIK)
Indivior Ord (INDV)
Establishment Labs Holdings Ord (ESTA)
Inhibikase Therapeutics Com New (IKT)
Urogen Pharma (URGN)
Xoma Corp Com New (XOMA)
Day One Biopharmaceuticals I (DAWN)

View all positions for Stonepine Capital Management

Top funds holding Alimera Sciences Inc Cvr

Stonepine Capital Management

View all funds holding Alimera Sciences Inc Cvr